TGF-βR1抑制剂
英文名 | LY2157299 | CAS号 | 700874-72-2 |
试剂别名 |
Galunisertib;6-[2-(6-Methylpyridin-2-yl)-acetyl]quinoxaline;2-(6-methyl-pyridin-2-yl)-3-(6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole;2-(6-Methyl-pyridin-2-yl)-1-quinoxalin-6-yl-ethanone;LY-2157299;LY 2157299 (LY-2157299);Galunisertib (LY2157299);6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-;4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo-[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide;2-(6-methylpyridin-2-yl)-3-(6-aminocarbonylquinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole;LY2157299
|
分子式 | C22H19N5O |
产品编号 | APEA8348 | 分子量 | 369.43 |
MDL号 |
产品名称: | TGF-βR1抑制剂 |
英文名称: | LY2157299 |
英文别名: | Galunisertib;6-[2-(6-Methylpyridin-2-yl)-acetyl]quinoxaline;2-(6-methyl-pyridin-2-yl)-3-(6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole;2-(6-Methyl-pyridin-2-yl)-1-quinoxalin-6-yl-ethanone;LY-2157299;LY 2157299 (LY-2157299);Galunisertib (LY2157299);6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-;4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo-[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide;2-(6-methylpyridin-2-yl)-3-(6-aminocarbonylquinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole;LY2157299 |
中文别名: | Galunisertib (LY2157299) 抑制剂;4-[5,6-二氢-2-(6-甲基-2-吡啶基)-4H-吡咯并[1,2-B]吡唑-3-基]-6-喹啉甲酰胺 |
CAS No.: | 700874-72-2 |
分子式: | C22H19N5O |
分子量: | 369.43 |
危险品级别: | |
HS符号: | |
危害声明: |